Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications.

heterogeneity implication molecular level thyroid cancer tumor ecosystem

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
07 Jan 2022
Historique:
received: 06 12 2021
revised: 04 01 2022
accepted: 05 01 2022
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 22 1 2022
Statut: epublish

Résumé

Though heterogeneity of cancers is recognized and has been much discussed in recent years, the concept often remains overlooked in different routine examinations. Indeed, in clinical or biological articles, reviews, and textbooks, cancers and cancer cells are generally presented as evolving distinct entities rather than as an independent heterogeneous cooperative cell population with its self-oriented biology. There are, therefore, conceptual gaps which can mislead the interpretations/diagnostic and therapeutic approaches. In this short review, we wish to summarize and discuss various aspects of this dynamic evolving heterogeneity and its biological, pathological, clinical, diagnostic, and therapeutic implications, using thyroid carcinoma as an illustrative example.

Identifiants

pubmed: 35053446
pii: cancers14020280
doi: 10.3390/cancers14020280
pmc: PMC8773841
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Front Cell Dev Biol. 2021 Mar 01;9:641469
pubmed: 33732706
Nat Med. 2018 Oct;24(10):1559-1567
pubmed: 30224757
Int J Mol Sci. 2016 Dec 06;17(12):
pubmed: 27929428
Front Endocrinol (Lausanne). 2020 Feb 13;11:44
pubmed: 32117069
PLoS Med. 2016 Dec 6;13(12):e1002174
pubmed: 27923045
J Exp Clin Cancer Res. 2020 May 27;39(1):95
pubmed: 32460897
Cancer Cell Int. 2019 Dec 18;19:341
pubmed: 31866766
Science. 2016 Jul 1;353(6294):78-82
pubmed: 27365449
Nat Rev Genet. 2021 Oct;22(10):627-644
pubmed: 34145435
Nat Med. 2021 Feb;27(2):212-224
pubmed: 33574607
Nature. 2019 May;569(7758):672-678
pubmed: 31092925
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):2140-5
pubmed: 26858460
Cancer Metastasis Rev. 2018 Dec;37(4):577-597
pubmed: 30465162
Int J Endocrinol. 2018 Jul 5;2018:1742951
pubmed: 30123257
Int J Endocrinol. 2013;2013:856189
pubmed: 23653645
Cancers (Basel). 2020 Apr 30;12(5):
pubmed: 32365785
Cancer Metastasis Rev. 2018 Dec;37(4):655-663
pubmed: 30484007
Cell. 2017 Feb 9;168(4):613-628
pubmed: 28187284
Cancer Metastasis Rev. 2019 Jun;38(1-2):205-222
pubmed: 30911978
Br J Cancer. 2020 Oct;123(8):1209-1218
pubmed: 32728094
Cancer Res. 2019 Jun 15;79(12):3011-3027
pubmed: 31053634
J Clin Invest. 2016 Mar 1;126(3):1052-66
pubmed: 26878173
Nature. 2019 Jan;565(7739):301-303
pubmed: 30643303
J Cell Biol. 2017 Nov 6;216(11):3799-3816
pubmed: 29021221
Nat Med. 2019 May;25(5):711-712
pubmed: 31036881
Front Endocrinol (Lausanne). 2020 Mar 13;11:102
pubmed: 32231639
Mol Cell Endocrinol. 2018 Feb 15;462(Pt B):93-106
pubmed: 28119133
Clin Cancer Res. 2018 May 1;24(9):2214-2224
pubmed: 29203589
Nat Med. 2018 May;24(4):463-473
pubmed: 29529015
J Mol Med (Berl). 2017 Nov;95(11):1167-1178
pubmed: 28871446
Cancers (Basel). 2020 May 14;12(5):
pubmed: 32422889
Diagn Pathol. 2019 Nov 20;14(1):130
pubmed: 31747942
Nat Rev Cancer. 2017 Oct;17(10):577-593
pubmed: 28912578
Cancer Discov. 2016 Feb;6(2):147-153
pubmed: 26644315
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Endocr Pathol. 2019 Dec;30(4):250-261
pubmed: 31664609
Front Oncol. 2021 Jul 29;11:683793
pubmed: 34395251
Am J Hum Genet. 2019 Nov 7;105(5):959-973
pubmed: 31668701
Adv Exp Med Biol. 2021;1311:205-214
pubmed: 34014545
Cancer Res. 2018 Jul 1;78(13):3445-3457
pubmed: 29760045
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
J Biol Chem. 2017 Oct 13;292(41):16825-16832
pubmed: 28842498
Front Endocrinol (Lausanne). 2020 Oct 22;11:570604
pubmed: 33193087
Neoplasia. 2016 Dec;18(12):742-752
pubmed: 27889643
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Thyroid. 2019 Jun;29(6):845-857
pubmed: 30990120
Diagnostics (Basel). 2020 Apr 03;10(4):
pubmed: 32260152
Nat Rev Clin Oncol. 2019 Mar;16(3):151-167
pubmed: 30523282
Mol Cancer. 2018 Feb 19;17(1):51
pubmed: 29455653
Ecancermedicalscience. 2017 Feb 23;11:721
pubmed: 28275390
Curr Opin Genet Dev. 2014 Feb;24:23-9
pubmed: 24657533
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Science. 2017 Dec 15;358(6369):1443-1448
pubmed: 29170280
Endocrinol Metab (Seoul). 2017 Sep;32(3):326-331
pubmed: 28956361
Bioinformatics. 2021 Jun 16;37(10):1452-1460
pubmed: 33275142
Front Endocrinol (Lausanne). 2021 Apr 27;11:637826
pubmed: 33986723
Nature. 2019 Aug;572(7771):603-608
pubmed: 31462798
Cancer Cell. 2019 Apr 15;35(4):618-632.e6
pubmed: 30930118
Nat Rev Urol. 2021 Feb;18(2):79-92
pubmed: 33328650
J Clin Endocrinol Metab. 2018 Mar 1;103(3):1102-1111
pubmed: 29342254
Int J Mol Sci. 2019 Sep 07;20(18):
pubmed: 31500315
Am J Cancer Res. 2019 Nov 01;9(11):2413-2427
pubmed: 31815043
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Nature. 2018 Jan 24;553(7689):446-454
pubmed: 29364287
Cold Spring Harb Symp Quant Biol. 2016;81:269-274
pubmed: 28389596
Front Endocrinol (Lausanne). 2020 May 22;11:82
pubmed: 32528402
J Endocrinol. 2017 Nov;235(2):R43-R61
pubmed: 28838947
FEBS J. 2018 Feb;285(4):700-716
pubmed: 29055087
Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6010-E6019
pubmed: 29895694
Mol Cell Endocrinol. 2022 Feb 5;541:111491
pubmed: 34740746
Acta Endocrinol (Buchar). 2019 Apr-Jun;15(2):203-208
pubmed: 31508177
Ann Oncol. 2019 Aug 1;30(8):1254-1264
pubmed: 31046106
Semin Cancer Biol. 2018 Aug;51:12-21
pubmed: 29366906
Cancers (Basel). 2020 Aug 11;12(8):
pubmed: 32796774
Trends Cancer. 2021 May;7(5):400-409
pubmed: 33243702
N Engl J Med. 2018 Apr 05;378(14):1323-1334
pubmed: 29617578
Int J Mol Sci. 2020 Jul 13;21(14):
pubmed: 32668761
BMC Cancer. 2019 Mar 4;19(1):196
pubmed: 30832606
Nature. 2019 Oct;574(7776):45-56
pubmed: 31578484
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Science. 2017 Mar 17;355(6330):1147-1152
pubmed: 28302822
Biochim Biophys Acta. 2012 Dec;1826(2):423-33
pubmed: 22841746
Cancers (Basel). 2020 Feb 07;12(2):
pubmed: 32046148
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):7-15
pubmed: 28110019
Anticancer Res. 2003 May-Jun;23(3B):2349-53
pubmed: 12894514
Cancer Res. 2016 Jun 1;76(11):3136-44
pubmed: 27009166
Horm Cancer. 2020 Oct;11(5-6):205-217
pubmed: 32548798
Cancer Res. 2018 Mar 1;78(5):1321-1333
pubmed: 29259015
Oncogene. 2017 May 11;36(19):2637-2642
pubmed: 27797377
Cancer Res. 2019 May 1;79(9):2111-2123
pubmed: 30877103
Int J Mol Sci. 2019 Mar 20;20(6):
pubmed: 30897754
Nat Rev Cancer. 2018 Apr;18(4):211-223
pubmed: 29422598
FASEB J. 2018 Jan;32(1):83-96
pubmed: 28883041
Cancers (Basel). 2020 Aug 04;12(8):
pubmed: 32759760
Transl Lung Cancer Res. 2020 Apr;9(2):246-256
pubmed: 32420064
Mol Cell. 2019 Jul 11;75(1):7-12
pubmed: 31299208
Nat Commun. 2017 May 05;8:15081
pubmed: 28474673
Endocr Relat Cancer. 2019 Mar 1;26(3):R131-R143
pubmed: 30615595
Cell. 2017 Aug 24;170(5):825-827
pubmed: 28841415
Biochim Biophys Acta Rev Cancer. 2018 Aug;1870(1):2-14
pubmed: 29702206
Cell. 2020 Mar 5;180(5):915-927.e16
pubmed: 32084333
J Intern Med. 2016 Jun;279(6):541-62
pubmed: 26748421
Curr Colorectal Cancer Rep. 2017 Aug;13(4):341-351
pubmed: 29129972
Front Immunol. 2017 Dec 14;8:1736
pubmed: 29312292
J Pathol. 2018 Apr;244(5):628-637
pubmed: 29344964
J Cell Physiol. 2019 May;234(5):5700-5721
pubmed: 30378106
Biochim Biophys Acta. 2016 Aug;1866(1):76-86
pubmed: 27343712
Cancer Res. 2016 Apr 1;76(7):1804-13
pubmed: 26818109
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):151-161
pubmed: 28110020
Nat Rev Cancer. 2018 Jan;18(1):19-32
pubmed: 29217838
FEBS J. 2018 Feb;285(4):641-653
pubmed: 28857430
Science. 2017 Nov 17;358(6365):941-946
pubmed: 29025995
Antioxid Redox Signal. 2018 Dec 1;29(16):1660-1690
pubmed: 29113454
J Cell Biochem. 2019 Mar;120(3):2791-2800
pubmed: 30260049
Front Endocrinol (Lausanne). 2019 Nov 08;10:759
pubmed: 31781034
Sci Adv. 2021 Apr 21;7(17):
pubmed: 33883145
J Mol Cell Biol. 2021 Feb 15;12(11):906-908
pubmed: 32573704
Thyroid. 2005 May;15(5):432-8
pubmed: 15929664
J Hepatol. 2018 Nov;69(5):1057-1065
pubmed: 30030148
Cold Spring Harb Perspect Med. 2016 Aug 01;6(8):
pubmed: 27481837
Nature. 2019 Jan;565(7739):312-317
pubmed: 30602793
Nat Rev Clin Oncol. 2016 Jun;13(6):335-47
pubmed: 26483300
Nat Med. 2016 Mar;22(3):262-9
pubmed: 26828195
Cell Commun Signal. 2020 Apr 7;18(1):59
pubmed: 32264958
Br J Cancer. 2020 Jan;122(2):133-135
pubmed: 31819199
Sci Rep. 2019 May 29;9(1):8028
pubmed: 31142771
J Exp Med. 2018 Jun 4;215(6):1693-1708
pubmed: 29769248
Nat Rev Genet. 2017 Dec;18(12):703
pubmed: 29109522
Cell Metab. 2016 Aug 9;24(2):311-23
pubmed: 27508876
Nat Rev Cancer. 2014 Feb;14(2):135-46
pubmed: 24457417
Science. 2017 Dec 1;358(6367):
pubmed: 29191879
Exp Cell Res. 2016 May 15;344(1):53-66
pubmed: 27112989
Nature. 2018 Feb 8;554(7691):189-194
pubmed: 29420467
Semin Cell Dev Biol. 2017 Apr;64:48-57
pubmed: 27717679
Cell. 2017 Dec 14;171(7):1611-1624.e24
pubmed: 29198524
Cancers (Basel). 2020 Nov 05;12(11):
pubmed: 33167363
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Oncotarget. 2017 Dec 8;9(12):10343-10359
pubmed: 29535811
Nat Genet. 2020 Mar;52(3):342-352
pubmed: 32024997
Nat Rev Endocrinol. 2017 Nov;13(11):644-660
pubmed: 28707679
Biomark Res. 2019 Oct 31;7:23
pubmed: 31695915
Science. 2019 Aug 2;365(6452):
pubmed: 31371581
Cancer Res. 2017 Dec 1;77(23):6551-6561
pubmed: 28972072
Endocr Relat Cancer. 2020 May;27(5):R113-R132
pubmed: 32191916
Int J Oncol. 2013 May;42(5):1589-96
pubmed: 23467725
Ann R Coll Surg Engl. 2017 Feb;99(2):151-154
pubmed: 27659362
Cancer Cell. 2018 Apr 9;33(4):543-544
pubmed: 29634941
Cancer Cell. 2018 Apr 9;33(4):607-619.e15
pubmed: 29634948
Pathobiology. 2018;85(1-2):117-129
pubmed: 29408820
BMC Cancer. 2018 May 2;18(1):504
pubmed: 29720111
J Exp Med. 2018 Jan 2;215(1):115-140
pubmed: 29191914
EMBO J. 2019 Jul 15;38(14):e100330
pubmed: 31304632
N Biotechnol. 2020 Mar 25;55:30-35
pubmed: 31580921
Front Oncol. 2020 Apr 07;10:472
pubmed: 32318350
Trends Cancer. 2021 Mar;7(3):265
pubmed: 33596415
J Hematol Oncol. 2019 Dec 29;12(1):142
pubmed: 31884964
J Clin Pathol. 2018 May;71(5):467-471
pubmed: 29317515
J Cancer Res Clin Oncol. 2018 Oct;144(10):1967-1990
pubmed: 29926160
CA Cancer J Clin. 2021 Jul;71(4):333-358
pubmed: 33982817
Lancet. 2017 Oct 21;390(10105):1833-1842
pubmed: 28855077
PLoS One. 2012;7(10):e37807
pubmed: 23115614
Am J Physiol Regul Integr Comp Physiol. 2017 Dec 1;313(6):R646-R653
pubmed: 28835450
Oncol Lett. 2019 Aug;18(2):1579-1584
pubmed: 31423225
Mol Cancer Res. 2018 Apr;16(4):655-668
pubmed: 29330292
Cancer Gene Ther. 2021 Sep;28(9):984-999
pubmed: 33712707
Cell. 2017 Nov 16;171(5):1029-1041.e21
pubmed: 29056346
Nat Rev Cancer. 2016 Jan;16(1):43-55
pubmed: 26678315
Int J Mol Sci. 2019 Aug 13;20(16):
pubmed: 31412566
Cell. 2016 Feb 11;164(4):681-94
pubmed: 26853473

Auteurs

Valerie Jacquemin (V)

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1070 Brussels, Belgium.

Mathieu Antoine (M)

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1070 Brussels, Belgium.

Geneviève Dom (G)

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1070 Brussels, Belgium.

Vincent Detours (V)

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1070 Brussels, Belgium.

Carine Maenhaut (C)

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1070 Brussels, Belgium.

Jacques E Dumont (JE)

Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1070 Brussels, Belgium.

Classifications MeSH